Integra Lifesciences (IART)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2005 | 12-2004 | 09-2004 | 06-2004 | 03-2004 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 32,763 | 69,855 | 34,912 | 42,540 | 76,052 |
| Marketable Securities | 43,705 | 30,955 | 38,479 | 25,841 | 30,118 |
| Receivables | 51,261 | 46,765 | 38,028 | 35,651 | 30,322 |
| Inventories | 65,335 | 55,947 | 52,400 | 50,509 | 44,894 |
| Income taxes - deferred | N/A | 3,966 | N/A | N/A | N/A |
| TOTAL | $204,958 | $216,238 | $174,060 | $164,187 | $189,740 |
| Non-Current Assets | |||||
| PPE Net | 27,685 | 25,461 | 22,433 | 22,540 | 20,213 |
| Investments And Advances | 81,463 | 95,172 | 117,607 | 125,855 | 105,911 |
| Intangibles | 142,336 | 99,054 | 98,711 | 99,435 | 81,109 |
| Other Non-Current Assets | 13,965 | 20,788 | 27,376 | 23,383 | 24,166 |
| TOTAL | $265,449 | $240,475 | $266,127 | $271,213 | $231,399 |
| Total Assets | $470,407 | $456,713 | $440,187 | $435,400 | $421,139 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 14,543 | 10,160 | 8,332 | 6,630 | 6,878 |
| Accrued Expenses | 14,514 | 13,052 | 14,000 | 15,177 | 12,816 |
| TOTAL | $30,979 | $24,234 | $23,766 | $23,184 | $19,694 |
| Non-Current Liabilities | |||||
| Long Term Debt | 118,631 | 118,900 | 119,220 | 118,336 | 119,742 |
| Other Non-Current Liabilities | 6,165 | 5,756 | 4,566 | 5,608 | 3,688 |
| TOTAL | $125,083 | $124,656 | $123,786 | $123,944 | $123,430 |
| Total Liabilities | $156,062 | $148,890 | $147,552 | $147,128 | $143,124 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 58,783 | 58,623 | 57,678 | 57,538 | 57,122 |
| Common Shares | 293 | 292 | 290 | 290 | 287 |
| Retained earnings | 8,178 | -265 | -10,104 | -2,506 | -10,024 |
| Other shareholders' equity | 1,483 | 6,194 | 3,732 | 2,754 | 4,132 |
| TOTAL | $314,345 | $307,823 | $292,635 | $288,272 | $278,015 |
| Total Liabilities And Equity | $470,407 | $456,713 | $440,187 | $435,400 | $421,139 |